Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
147,940,971
-
Share change
-
+729,773
-
Total reported value
-
$3,081,594,094
-
Put/Call ratio
-
149%
-
Price per share
-
$20.83
-
Number of holders
-
202
-
Value change
-
+$9,562,009
-
Number of buys
-
116
-
Number of sells
-
77
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q3 2018
As of 30 Sep 2018 IMMUNOMEDICS INC - COM (IMMU) had 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 147,940,971 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., STATE STREET CORP, FMR LLC, Palo Alto Investors LP, ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, and JANUS HENDERSON GROUP PLC.
This table shows 202 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.